New drug tested for Tough-to-Treat lung cancer
NCT ID NCT05662670
Summary
This early-stage study tested a new drug called WJ13405 for people with advanced non-small cell lung cancer that had stopped responding to standard treatments. The trial aimed to find a safe dose and see if the drug could help control cancer growth, particularly for patients with a specific genetic mutation called EGFR C797X. The study was terminated after enrolling 14 participants to evaluate safety and early signs of effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.